Related Experiment Video

Updated: Jul 13, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

[Spectrum and risk factors of invasive fungal infection]

Juan José Castón Osorio1, Antonio Rivero Román, Julián Torre-Cisneros

  • 1Unidad de Gestión Clínica de Enfermedades Infecciosas, Hospital Universitario Reina Sofía, Córdoba, España. juanjoco2005@yahoo.es

Enfermedades Infecciosas Y Microbiologia Clinica
|August 19, 2007
PubMed

Insights

Invasive fungal infections are increasing in immunosuppressed patients, with a shift from Candida to Aspergillus and molds. New risk factors and timing necessitate updated clinical management strategies for these infections.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Medicine

Context:

  • Invasive fungal infections (IFIs) pose a significant threat to immunosuppressed patient populations.
  • Shifting epidemiological trends show a rise in filamentous mold infections, such as Aspergillus, over Candida species.
  • Changes in medical practices, including azole antifungal prophylaxis, influence the epidemiology of IFIs.

Purpose:

  • To highlight the evolving landscape of invasive fungal infections in immunosuppressed patients.
  • To underscore the impact of changing medical practices on fungal infection patterns.
  • To emphasize the need for updated clinical recognition and management strategies.

Summary:

  • Invasive fungal infections are increasingly prevalent in immunosuppressed individuals.
  • Medical practice changes, like azole prophylaxis, have driven a shift in causative agents from Candida to Aspergillus and other molds.
  • Emerging risk factors and altered onset times require attention for effective patient care.

Impact:

  • Clinicians must recognize these epidemiological shifts for timely diagnosis and treatment.
  • Understanding new risk factors and onset patterns is crucial for managing IFIs in patients on novel immunosuppressive regimens.
  • Adapting clinical management strategies is essential to improve outcomes for immunosuppressed patients facing evolving fungal threats.

More Related Videos

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...